Buée L - Search Results

1

Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.

Albert M, Mairet-Coello G, Danis C, Lieger S, Caillierez R, Carrier S, Skrobala E, Landrieu I, Michel A, Schmitt M, Citron M, Downey P, Courade JP, Buée L, Colin M. Albert M, et al. Among authors: buee l. Brain. 2019 Jun 1;142(6):1736-1750. doi: 10.1093/brain/awz100. Brain. 2019. PMID: 31038156 Free PMC article.

2

Specific pathological Tau protein variants characterize Pick's disease.

Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D. Delacourte A, et al. Among authors: buee l. J Neuropathol Exp Neurol. 1996 Feb;55(2):159-68. doi: 10.1097/00005072-199602000-00004. J Neuropathol Exp Neurol. 1996. PMID: 8786374

3

Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.

Buée-Scherrer V, Buée L, Leveugle B, Perl DP, Vermersch P, Hof PR, Delacourte A. Buée-Scherrer V, et al. Among authors: buee l. Ann Neurol. 1997 Sep;42(3):356-9. doi: 10.1002/ana.410420312. Ann Neurol. 1997. PMID: 9307257

4

Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation.

Mailliot C, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L. Mailliot C, et al. Among authors: buee l. Neurosci Lett. 1998 Oct 9;255(1):13-6. doi: 10.1016/s0304-3940(98)00693-4. Neurosci Lett. 1998. PMID: 9839715

5

Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.

Bussière T, Hof PR, Mailliot C, Brown CD, Caillet-Boudin ML, Perl DP, Buée L, Delacourte A. Bussière T, et al. Among authors: buee l. Acta Neuropathol. 1999 Mar;97(3):221-30. doi: 10.1007/s004010050978. Acta Neuropathol. 1999. PMID: 10090668

6

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

Delacourte A, David JP, Sergeant N, Buée L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C. Delacourte A, et al. Among authors: buee l. Neurology. 1999 Apr 12;52(6):1158-65. doi: 10.1212/wnl.52.6.1158. Neurology. 1999. PMID: 10214737

7

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. Buée L, et al. Among authors: buee scherrer v. Brain Res Brain Res Rev. 2000 Aug;33(1):95-130. doi: 10.1016/s0165-0173(00)00019-9. Brain Res Brain Res Rev. 2000. PMID: 10967355 Review.

8

Tau pathology: a marker of neurodegenerative disorders.

Delacourte A, Buée L. Delacourte A, et al. Among authors: buee l. Curr Opin Neurol. 2000 Aug;13(4):371-6. doi: 10.1097/00019052-200008000-00002. Curr Opin Neurol. 2000. PMID: 10970052 Review.

9

[Tau story: from frontotemporal dementia to other tauopathies].

Buée L, Hamdane M, Delobel P, Sambo AV, Bégard S, Ghestem A, Sergeant N, Delacourte A. Buée L, et al. J Soc Biol. 2002;196(1):103-8. J Soc Biol. 2002. PMID: 12134624 Review. French.

10

Pin1: a therapeutic target in Alzheimer neurodegeneration.

Hamdane M, Smet C, Sambo AV, Leroy A, Wieruszeski JM, Delobel P, Maurage CA, Ghestem A, Wintjens R, Bégard S, Sergeant N, Delacourte A, Horvath D, Landrieu I, Lippens G, Buée L. Hamdane M, et al. Among authors: buee l. J Mol Neurosci. 2002 Dec;19(3):275-87. doi: 10.1385/JMN:19:3:275. J Mol Neurosci. 2002. PMID: 12540053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters